Navigation Links
Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
Date:10/9/2009

The National Institutes of Health (NIH) has awarded a “Grand Opportunity” (GO) grant to a team of researchers – led by Todd Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, PhD, of Hebrew University – to use cutting-edge technologies to help unravel the genetic basis of schizophrenia. More than two million dollars was awarded to the team, which also includes Anil Malhotra, MD, and Peter Gregersen, MD, of the Feinstein Institute and David Goldman, MD, of the National Institute of Alcohol Abuse and Alcoholism, to conduct this research.

Manhasset, NY (Vocus) October 9, 2009 -- The National Institutes of Health (NIH) has awarded a “Grand Opportunity” (GO) grant to a team of researchers – led by Todd Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, PhD, of Hebrew University – to use cutting-edge technologies to help unravel the genetic basis of schizophrenia. More than two million dollars was awarded to the team, which also includes Anil Malhotra, MD, and Peter Gregersen, MD, of the Feinstein Institute and David Goldman, MD, of the National Institute of Alcohol Abuse and Alcoholism, to conduct this research.

As described by the NIH, the GO grant program was designed to support “high impact ideas” that can “accelerate critical breakthroughs” in our understanding of human disease. The program was made possible by an infusion of money to the NIH under the American Recovery and Reinvestment Act (also known as the “economic stimulus package”), representing “the single largest boost to biomedical research in history,” according to President Barack Obama. In announcing the awards, President Obama singled out genetic research as “one of the most exciting areas of research to move forward as a result of this investment.” Eventually, it is hoped that this research may be used to more accurately predict, treat, and prevent serious mental illnesses such as schizophrenia.

It has long been known that schizophrenia – a complex brain disease marked by hallucinations and delusions – tends to run in families and therefore has a genetic component to its cause. However, scientists have struggled to conclusively identify the genes that contribute to risk for this disease. “Current evidence suggests that many genes are likely to be involved in schizophrenia, which theoretically should provide a large target for scientists,” Dr. Lencz said. “Unfortunately, these genes are individually either very rare or very weak in effect, making them very elusive to traditional forms of genetic analysis.”

The newly funded GO grant builds on prior gene-hunting efforts with several distinctive features. Most notably, the sample consists entirely of individuals (patients and controls) of Ashkenazi Jewish descent, recruited in Israel by Dr. Darvasi, who explains “The unique demographic history of the Jewish Ashkenazi population results in a more homogeneous genetic background compared to the general population. This should allow disease-related genetic signals to stand out more clearly in our analyses.” Additionally, this study will utilize the most advanced genetic technologies, which will permit examination of many more pieces of the genetic code than prior generations of research.

###

Read the full story at http://www.prweb.com/releases/Feinstein_Grant/Genetics_Schizophrenia/prweb3021604.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
2. The Feinstein to collaborate with Swedens Karolinska Institute
3. Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
4. Feinstein Institute: Researching a Family Tree of Autoimmune Disorders
5. Senator Dianne Feinstein Denounces Prop 8
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Senators Feinstein and Boxer Vote to Protect Americas Kids from Tobacco
8. Stephen H. Feinstein, Ph.D., of Kansas Elected NAMI National Board President
9. The Feinstein Institute for Medical Research Discovers the Role of Progesterone and Pre-Term Labor
10. 1,200 Nurses Make a House Call to Dianne Feinstein To Demand She Cosponsor Employee Free Choice Act
11. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to take ... rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, ... Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... new medical office in Petaluma, located at 167 Lynch Creek Way. The Petaluma ... SRO sports medicine and rehabilitation services and on-site x-ray services. Two ...
(Date:1/20/2017)... ... ... Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift ... can be wheeled out of the way and stored when not in use. It is ... the feedback from customers into specific enhancements and created a new product that is built ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a ... percent pure essential oils, announced the company had a successful visit to the 2017 ... ECRM event gives companies that work in the nutritional, sports and health industries a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange ... excited to announce that the first five replication ...  (RP:CB) have been published in eLife today. Despite ... represents the first practical evaluation of reproducibility rates ... reproducible studies. Unlike other assessments of reproducibility, the ...
Breaking Medicine Technology: